Private Equity

Updated:

Beyond Impact

Beyond Impact manages early-stage investments in alternative proteins and sustainable materials across multiple regions.

Beyond Impact logo

Beyond Impact

Beyond Impact was established to back companies in vegan and cruelty-free alternatives. Its mandate centers on alternative proteins, precision fermentation, cellular agriculture, sustainable materials, and related technologies. The firm deploys via Alternative VC Models, Direct Co-Investments / SPVs, and Philanthropic / Mission-Related Investing. Confirmed stages include Seed, Early Stage, and Growth. Positions target startups with superior products that address health risks and demand for ethical options. Geographic coverage spans North America, Europe, Asia, and the Middle East & Central Asia. Sector focus remains fixed on AgriTech & FoodTech and ClimateTech. Technology emphases include Advanced Materials, Biotech, and ESG. No additional offices, team size, or adjacent vehicles are recorded. The structure relies on mission-related vehicles that combine venture commitments with philanthropic overlays, distinguishing it from pure financial sponsors.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

Switzerland

City

Montreux

Corporate office

Montreux, Switzerland

Sector focus

AgriTech & FoodTechClimateTech

Frequently asked questions

Who runs investment decisions at Beyond Impact?

No named principals or investment committee members appear in available records.

How does Beyond Impact source proprietary deal flow?

The firm uses direct co-investments and SPVs alongside its fund vehicles.

Does Beyond Impact participate in fund commitments or only direct deals?

It uses both diversified funds such as Beyond Impact Ventures and direct co-investments.

What investment stages does Beyond Impact typically target?

Seed, Early Stage, and Growth.

Which sectors does Beyond Impact explicitly target?

AgriTech & FoodTech and ClimateTech, with emphasis on alternative proteins and cellular agriculture.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Montreux Private Equity profiles